Skip to main content

Table 2 Baseline characteristics of the study population

From: Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis

Sample size36,816
Observed quarters342,406
Mean (SD) follow up in completed quarters9.3 (5.7)
Male, n (%) gender20,703 (56.2)
Mean (SD) age at diagnosis in years64.7 (14.6)
ILD subtype
 IIP14,453 (39.3)
 OFI7186 (19.5)
 SARC9106 (24.7)
 DAI407 (1.1)
 PNE1575 (4.3)
 RAP464 (1.3)
 EPP1518 (4.1)
 HSP967 (2.6)
 CTD1140 (3.1)
Quarters between suspected ILD and confirmed ILD, mean (SD)2.1 (4.6)
  1. DAI Drug-Associated ILDs, CTD Connective Tissue-associated ILD, EPP Eosinophilic Pneumonia, HSP Hypersensitivity Pneumonitis, IIP Idiopathic Interstitial Pneumonia, ILD interstitial lung disease, OFI Other Fibrosing ILDs, PNE Pneumoconiosis, RAP Radiation-Associated Pneumonitis, SARC Sarcoidosis